SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-085234
Filing Date
2022-03-25
Accepted
2022-03-25 16:44:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d293656ds3.htm S-3 299541
2 EX-5.1 d293656dex51.htm EX-5.1 19817
3 EX-23.1 d293656dex231.htm EX-23.1 1352
4 EX-FILING FEES d293656dexfilingfees.htm EX-FILING FEES 52668
5 GRAPHIC g293656g0324005243158.jpg GRAPHIC 1201
6 GRAPHIC g293656g08o90.jpg GRAPHIC 10531
7 GRAPHIC g293656g12s79.jpg GRAPHIC 59591
8 GRAPHIC g293656g15s86.jpg GRAPHIC 43622
9 GRAPHIC g293656g44a21.jpg GRAPHIC 56320
  Complete submission text file 0001193125-22-085234.txt   605624
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263863 | Film No.: 22771996
SIC: 2834 Pharmaceutical Preparations